SCHEMBL6036799

SCHEMBL6036799

O=C(O)Oc1cc2ccccc2oc1=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 8/20 0.58
CA12 O43570 2/20 0.58
CA9 Q16790 2/20 0.58
CA1 P00915 1/20 0.58
CA3 P07451 1/20 0.58
TSHR P16473 1/20 0.58
CA4 P22748 1/20 0.58
CA6 P23280 1/20 0.58
CA5A P35218 1/20 0.58
CA7 P43166 1/20 0.58
GPR35 Q9HC97 1/20 0.58
CA14 Q9ULX7 1/20 0.58
CA5B Q9Y2D0 1/20 0.58
KDM4E B2RXH2 6/20 0.57
ALDH1A1 P00352 5/20 0.57
NPSR1 Q6W5P4 1/20 0.57
HPGD P15428 3/20 0.54
TYR P14679 1/20 0.54
DAO P14920 1/20 0.54
AKR1B1 P15121 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL4227922 0.87 KDM4E (0.58) MAOBCA12CA9CA1CA3
SCHEMBL1045399 0.87 KDM4E (0.61) MAOBCA12CA9CA1CA3
SCHEMBL27696165 0.86 CA12 (0.65) MAOBCA12CA9CA1CA3
Methyl Alcohol SCHEMBL27953712 0.85 KDM4E (0.59) MAOBCA12CA9CA1CA3
SCHEMBL11081635 0.85 HPGD (0.53) MAOBCA12CA9CA1CA3
SCHEMBL11075359 0.83 KDM4E (0.60) MAOBCA12CA9CA1CA3
SCHEMBL7537579 0.81 POLB (0.54) MAOBCA12CA9CA1CA3
Acetic Acid SCHEMBL155186 0.81 KMT2A (0.60) MAOBCA12CA9CA1CA3
SCHEMBL8764982 0.81 POLB (0.57) CA12CA9CA1KDM4EALDH1A1
SCHEMBL28437671 0.80 HPGD (0.58) MAOBCA12CA9CA1CA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1607446-B1 ORGANIC/INORGANIC HYBRID MATERIAL, COMPOSITION FOR SYNTHESIZING THE SAME AND PROCESS FOR PRODUCING THE HYBRID MATERIAL SEMICONDUCTOR ENERGY LAB (JP) 2016-09-07 EP claimed
EP-1185869-B1 LIGAND-ANCHOR CONJUGATES FOR PRODUCING A BIOSENSOR LAYER GRAFFINITY PHARMACEUTICALS AG (DE) 2006-07-26 EP disclosed
EP-1280799-B1 ORTHO-SUBSTITUTED ANTHRANILIC ACID AMIDES AND THEIR USE AS MEDICAMENTS SCHERING AG (DE) 2004-01-21 EP disclosed
EP-1185869-A2 LIGAND-ANCHOR CONJUGATES FOR PRODUCING A BIOSENSOR LAYER Graffinity Pharmaceutical Design GmbH (DE) 2002-03-13 EP disclosed
WO-2001085719-A9 ORTHO-SUBSTITUTED ANTHRANILIC ACID AMIDES AND THEIR USE AS MEDICAMENTS SCHERING AG (DE) 2001-12-27 WO disclosed
WO-2000073796-A2 LIGAND-ANCHOR CONJUGATES FOR PRODUCING A BIOSENSOR LAYER GRAFFINITY PHARMACEUTICAL DESIGN GMBH (DE) 2000-12-07 WO disclosed
EP-0998674-A2 CONJUGATE FOR DIFFERENTIATING BETWEEN HEALTHY AND UNHEALTHY TISSUE Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) 2000-05-10 EP disclosed
WO-1999005521-A2 CONJUGATE FOR DIFFERENTIATING BETWEEN HEALTHY AND UNHEALTHY TISSUE Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) 1999-02-04 WO disclosed
EP-0798087-A1 Wood treatment agent DESOWAG GmbH (DE) 1997-10-01 EP disclosed
EP-0670833-A1 NITROXY COMPOUNDS WITH PHARMACEUTICAL PROPERTIES IOVIS BIOMEDICAL AND PHARMACEUTICAL CONSULTANTS (NL) 1995-09-13 EP disclosed
WO-1994012488-A1 NITROXY COMPOUNDS WITH PHARMACEUTICAL PROPERTIES BYK NEDERLAND BV (NL) 1994-06-09 WO disclosed